Market cap: $1,453,257,872
Exchange: NAS
Sector: Health Technology
NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Company Name
NovoCure Ltd
Average Volume (10 days)
1,060,823
Average Volume (30 days)
1,796,383
Moving Average (50 days)
$14.91
Moving Average (200 days)
$14.12
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
-7.0191
Market Cap
1,453,257,872
Shares Outstanding
107,093,432
52-Week High Split Adjust Only
83.6
52-Week Low Split Adjust Only
10.87
Employee Count
1,224
Beta
1.5904
Next Earnings Date
2024-05-02
TTM Dividend Rate Per Share
0
Past 5 days
-0.01%
Past 30 days
-0.11%
Past 3 months
0.01%
Past 6 months
-0.01%
Past year
-0.79%
Past 2 years
-0.84%
Past 5 years
-0.7%
Max % Change
-0.26%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| NovoCure Ltd | NVCR | 25.53 | 35.02 | 1.6 | 25.53 | 24.91 |
| Peer Avg | N/A | 12.48 | 15.18 | -5.5 | 12.48 | 11.71 |
| NovoCure Ltd | NVCR | 25.53 | 35.02 | 1.6 | 25.53 | 24.91 |
| Novavax, Inc. | NVAX | 11.90 | 10.53 | -18.0 | 11.90 | 10.22 |